Study on the Regulatory Effects of Personalized Innovative Youtiao Intervention on Nutritional Health
Launched by YU ZHANG · May 17, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Participants entered the trial with a 1-week equilibration period during which baked and fried foods were prohibited. The test group will consume personalised innovative Youtiao and the control group will uniformly consume traditional Youtiao of equal energy, 45 g 4 times per week for 8 weeks, during which time we will periodically measure biological indicators and collect biological samples to gain insight into the effects of the personalised innovative Youtiao on the participants. After completion of the 8-week intervention, a washout phase is entered. During this phase, participants will...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 40-70 years old (women need to be menopausal);
- • BMI\>24 kg/m2;
- • Consumption of fritters more than once a week.
- Exclusion Criteria:
- • history of diabetes mellitus, cardiovascular disease, dyslipidaemia, renal disease, -
- • liver disease or cancer;
- • surgical treatment within 3 months;
- • allergy/intolerance to the study food or any of its ingredients;
- • breastfeeding or pregnancy;
- • \>10% weight loss in the past 6 months;
- • smoking or alcohol abuse;
- • participation in another clinical study within the past 6 months
About Yu Zhang
Yu Zhang is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative studies. With a commitment to scientific rigor and ethical standards, Yu Zhang collaborates with leading researchers and healthcare professionals to design and implement clinical trials that explore new therapies and treatment modalities. By fostering a culture of transparency and collaboration, Yu Zhang aims to contribute to the development of groundbreaking solutions that address unmet medical needs and enhance the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0